Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?
Open Access
- 1 May 1997
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 99 (9), 2062-2070
- https://doi.org/10.1172/jci119377
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Characterization of ryudocan glycosaminoglycan acceptor sites.Journal of Biological Chemistry, 1994
- Smooth muscle cell expression of extracellular matrix genes after arterial injury.1994
- Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins.Journal of Biological Chemistry, 1994
- Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.Journal of Biological Chemistry, 1994
- Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior.Journal of Biological Chemistry, 1994
- cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin.Journal of Biological Chemistry, 1994
- Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.Journal of Biological Chemistry, 1994
- Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line.Journal of Biological Chemistry, 1994
- Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.Journal of Biological Chemistry, 1993
- Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.Journal of Biological Chemistry, 1993